TforG

OpenApp is an innovative software development company that focuses on the healthcare sector. Their specialties lie in utilizing open-source tools to deliver applications, systems & solutions. With extensive experience in health intelligence, geographic information, patient registries, and document management.

Pharmaspectra, LLC is a global provider of medical key opinion leader databases and scientific dissemination data for the healthcare, pharmaceutical, and biotechnology industries. The company offers various tools, including ProfileMeme, which allows users to search, sort, and analyze key opinion leader profiles in medical and biological sciences, and ConferenceMeme, a database for organizing and targeting medical conferences. Additionally, Pharmaspectra provides JournalMeme, an online platform for identifying and contacting advocates and researchers, and the Knowledge Discovery Platform, which tracks medical meetings and clinical research presentations. The company also features MEPmeme, a database offering information on medical education providers. Founded in 2004 and based in New York, Pharmaspectra was previously known as MedMeme, LLC before rebranding in August 2018.

AllCare Plus Pharmacy, located in Northborough, MA, is a specialty pharmacy known for its comprehensive pharmacy services and expertise in complex medication management. The pharmacy focuses on providing personalized care, combining clinical knowledge with innovative compliance programs to ensure effective treatment for challenging diseases. Additionally, AllCare Plus Pharmacy offers a range of patient support services, including reimbursement support, adherence programs, financial assistance, and non-commercial dispensing. By integrating these services, the pharmacy aims to simplify and enhance the treatment experience for individuals managing difficult health conditions.

RxWare is a SaaS company founded in 2013 that focuses on enhancing the patient experience for pharmaceutical drug manufacturers. The company offers a digital infrastructure that connects various components of the patient journey, simplifying the process for patients accessing therapy. Its Patient Gateway integrates with existing patient services, including ePrescribing systems, specialty pharmacies, and affordability solutions, facilitating improved resource utilization and therapy outcomes. RxWare's platform is designed to transform complex patient pathways into streamlined experiences, allowing drug manufacturers to optimize and accelerate patient journeys effectively.

BC Platforms provides a data and technology platform designed for life sciences and healthcare companies to access, manage, and analyze clinical and omics data. Its Data Access Platform offers valuable resources, including real-world data, clinical data, and genomic information, through a data-as-a-service model. The company's Data Partner Network encompasses over 22 million life-years of meticulously curated patient data from various global sources. This extensive data access allows pharmaceutical companies to enhance research and development processes, accelerating the transition from early discovery to clinical and post-market evaluations. BC Platforms also offers technology solutions that enable healthcare providers and life science organizations to manage and analyze complex genomic data, ensuring compliance with local privacy regulations and compatibility with relevant technical standards. Through its innovative platform, BC Platforms aims to improve decision-making in drug development and delivery, helping to address significant health challenges effectively.

Octopus.Health is a patient engagement platform for proactive population health. The company technology creates a Healthcare Personal Assistant that supports millions of patients and tailors a personalized proactive healthcare plan for each patient based on advanced machine learning algorithms. Octopus.Health leverages AI and Machine Learning to revolutionize how patient adherence is being managed today. It was founded in 2017 and is based in Tel Aviv, Israel.

Belong.Life, founded in 2015 by entrepreneurs Eliran Malki, Irad Deutsch, and Ohad Rubin, is a leader in healthcare technology focused on cancer care. The company offers a free patient navigation app called Belong, designed to assist cancer patients and their support networks in managing treatment journeys and enhancing quality of life. Additionally, Belong.Life has developed PEP, a comprehensive solution for healthcare organizations that includes personalized patient engagement tools, navigation, and management services. The platform leverages proprietary artificial intelligence and machine learning algorithms to streamline patient navigation, provide treatment templates and reminders, and analyze patient journeys. This approach allows healthcare clients to improve engagement, education, compliance, and overall efficiency in cancer care.

Linguamatics Limited specializes in developing text mining solutions leveraging semantic and natural language processing technology for the life sciences, pharmaceutical, and biotech sectors. The company offers its flagship product, I2E, which facilitates agile querying and reporting, alongside an Asynchronous Messaging Pipeline platform that automates insight discovery from unstructured text. Additionally, Linguamatics Health provides a clinical NLP suite designed for hospitals and research organizations to extract valuable information from electronic health records and patient narratives, ultimately driving healthcare analytics and improving patient outcomes. The software can also be applied in business intelligence, life sciences research, and social media analysis. Founded in 2001 and headquartered in Cambridge, United Kingdom, Linguamatics operates a subsidiary in Newton, Massachusetts, and has a strategic alliance with Selventa, Inc.

Beijing Naxions Technology Co., Ltd. specializes in digital marketing services tailored for the medical Internet sector. Founded in 2014 and headquartered in Chaoyang District, China, with additional offices in Shanghai, the company has developed a communication software solution that incorporates a SaaS platform. This platform enables real-time data analysis, progress visualization, and results digitization, thereby enhancing sales management for pharmaceutical companies. Naxions offers a range of services, including data capture, collection, scraping, cleaning, calculation, and presentation. Key features of its application include content sharing, project management, and customer analysis, all aimed at improving the efficiency and brand visibility of pharmaceutical enterprises while ensuring compliance with industry standards.

Advanced Health Media, LLC is a provider of software and services designed to manage engagements between healthcare professionals and the pharmaceutical industry. Founded in 1999 and headquartered in New Providence, New Jersey, the company offers a range of solutions including CentrisDirect for managing HCP engagement ecosystems, CentrisEngage for meetings, and CentrisIQ for business intelligence reporting. Advanced Health Media supports over 25 pharmaceutical companies, managing more than 150,000 events annually and has facilitated over one million pharmaceutical events since 2005. The company emphasizes continuous investment in its solutions to enhance customer experience, support strategic decision making, and ensure compliance reporting to reduce risk. With several hundred employees across global offices in locations such as Virginia, the Philippines, and the United Kingdom, Advanced Health Media aims to provide comprehensive and efficient services tailored to the life sciences sector.

ObvioHealth is a global digital health organization focused on enhancing the clinical trial process through innovative technology. The company offers a mobile clinical study application that facilitates site-less trials, enabling participants to engage in remote monitoring from their homes. This application supports continuous data collection, even between scheduled clinic visits, and fosters daily interaction through text messaging and chat features, promoting participant involvement. By connecting with various health devices such as wearables and smart health apps, ObvioHealth ensures comprehensive data gathering. Additionally, the app allows participants to schedule lab visits and manage compensation easily. The overall aim is to streamline the clinical trial process, resulting in improved data quality, increased compliance, faster recruitment, and reduced time to completion, thereby transforming the clinical research landscape.

COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.

DrugDev is a technology-driven company that offers a range of solutions designed to enhance the efficiency and collaboration in clinical trials. It operates the largest online network of clinical trial sites and provides a leading platform for investigator identification and startup processes. By integrating trial optimization systems and grants payment capabilities, DrugDev transforms how drug developers identify, engage, and compensate doctors involved in clinical research. The company also hosts the Investigator Databank, a collaborative initiative among major pharmaceutical companies aimed at increasing clinical trial opportunities and alleviating the administrative burdens faced by over 200,000 clinical trial professionals globally. Through its data-sharing platform, DrugDev fosters communication among doctors, contract research organizations, and investigators, promoting standards that enhance quality, reduce costs, and streamline timelines in clinical trials.

Pilgrim Quality Solutions, Inc. specializes in providing enterprise quality management software solutions tailored for the life sciences industry and other highly regulated sectors. The company's flagship product, SmartSolve, is a web-based suite that facilitates quality management, compliance, and risk management, enabling organizations to enhance quality, adhere to regulations, and mitigate risks. Pilgrim's solutions are designed for both on-premise and cloud deployment, allowing companies to effectively manage domestic and international operations. The software includes features for process automation, such as corrective and preventive actions management, document control, audit management, and employee certification. Founded in 1993 and based in Tampa, Florida, Pilgrim Quality Solutions has built a strong reputation for innovation and excellence, serving a diverse portfolio of global customers who rely on its products to navigate the complexities of compliance and quality assurance in a competitive marketplace.

Themis Analytics is a pharmaceutical data analytics company that specializes in managing and analyzing market data within the pharmaceutical industry. It provides a comprehensive platform that allows clients to check, integrate, and harmonize various types of data. The company focuses on data management, visualization, and reporting, enabling users to highlight essential insights and streamline their operations. Additionally, Themis Analytics offers full life cycle support, ensuring that decision-makers have access to the necessary information to make informed and strategic decisions for their businesses.

STI Technologies focuses on managing patient support programs and enhancing medication access by utilizing reimbursement funding and innovative technology to engage patients in their healthcare journey. The company develops intelligent solutions that assist various stakeholders in the healthcare system, offering financial reimbursement, patient engagement, and management solutions aimed at improving health outcomes. STI Technologies provides user-friendly solutions that are accessible online and through healthcare providers, including physicians and pharmacists across the nation. Additionally, the company has expanded its capabilities by acquiring a software development and managed network support services business, further strengthening its position in the healthcare technology sector.

ClioScience is a drug-raising venture company that develops of anti-cancer drugs and orphan drugs such as doctor-led clinical trials.

Aileron Solutions, LLC specializes in providing data and analytics services tailored for pharmaceutical and medical device manufacturers. Founded in 2009 and located in Conshohocken, Pennsylvania, the company offers a range of data products, including precision targeting claims data, physician affiliations data, and physician reference data. These products are designed to enhance the understanding of physician networks and patient flow. Aileron Solutions also delivers data management services, such as deduplication, record resolution, and data validation, alongside analytics services that focus on physician influence and network affiliations. The company's offerings are aimed at improving decision-making and operational efficiency within the healthcare industry.

Novella is a specialty contract research organization (CRO) that focuses exclusively on the distinct needs of small to mid-sized companies in the oncology sector, as well as medical device and diagnostics firms. The company has developed a flexible business model and possesses global capabilities, with a team of professionals who are well-versed in the specific requirements of oncology and medical device trials. In addition to its CRO services, Novella also acts as an organizational agency, facilitating communication, arranging conferences, and publishing customized materials for various organizations. This dual expertise allows Novella to effectively support its clients in navigating the complexities of clinical trials and organizational communication.